ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

被引：0
|
作者：
Ryan Marino
Jeanmarie Perrone
Lewis S. Nelson
Timothy J. Wiegand
Evan S. Schwarz
Paul M. Wax
Andrew I. Stolbach
机构：
[1] Case Western Reserve University School of Medicine,Division of Emergency Medicine
[2] University of Pennsylvania,undefined
[3] Rutgers New Jersey Medical School,undefined
[4] University of Rochester Medical Center,undefined
[5] Washington University School of Medicine,undefined
[6] University of Texas Southwestern,undefined
[7] Johns Hopkins University School of Medicine,undefined
来源：
Journal of Medical Toxicology | 2019年 / 15卷
关键词：
Buprenorphine; Waiver; X-waiver; Opioid use disorder; Opioid agonist therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：307 / 309
页数：2
相关论文
共 50 条
  • [1] ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder
    Marino, Ryan
    Perrone, Jeanmarie
    Nelson, Lewis S.
    Wiegand, Timothy J.
    Schwarz, Evan S.
    Wax, Paul M.
    Stolbach, Andrew I.
    JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (04) : 307 - 309
  • [2] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Ryan T. Marino
    Meghan Spyres
    Timothy J. Wiegand
    Kavita M. Babu
    Andrew Stolbach
    Journal of Medical Toxicology, 2022, 18 : 71 - 73
  • [3] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Paul M. Wax
    Andrew I. Stolbach
    Evan S. Schwarz
    Brandon J. Warrick
    Timothy J. Wiegand
    Lewis S. Nelson
    Journal of Medical Toxicology, 2019, 15 : 215 - 216
  • [4] ACMT Position Statement: Buprenorphine Administration in the Emergency Department
    Wax, Paul M.
    Stolbach, Andrew I.
    Schwarz, Evan S.
    Warrick, Brandon J.
    Wiegand, Timothy J.
    Nelson, Lewis S.
    JOURNAL OF MEDICAL TOXICOLOGY, 2019, 15 (03) : 215 - 216
  • [5] ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
    Marino, Ryan T.
    Spyres, Meghan
    Wiegand, Timothy J.
    Babu, Kavita M.
    Stolbach, Andrew
    JOURNAL OF MEDICAL TOXICOLOGY, 2022, 18 (01) : 71 - 73
  • [6] Survey of barriers and opportunities for prescribing buprenorphine for opioid use disorder in Alabama
    Patel, Ishika
    Li, Li
    Jeong, Haelim
    Mcdaniel, Justin T.
    Mcintosh, Shanna
    Robertson, Ellen
    Albright, David L.
    JOURNAL OF ADDICTIVE DISEASES, 2024, 42 (04) : 410 - 417
  • [7] US trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018
    Ghertner, Robin
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204
  • [8] Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care
    Ho, Jiunling Janet
    Jones, Katie Fitzgerald
    Sager, Zachary
    Neale, Kyle
    Childers, Julie W.
    Loggers, Elizabeth
    Merlin, Jessica S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 64 (02) : 119 - 127
  • [9] Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
    Rowe, Christopher L.
    Ahern, Jennifer
    Hubbard, Alan
    Coffin, Phillip O.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 132
  • [10] Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder
    Baylis, Jacob D.
    Jorgenson, Terri L.
    Pals, Haley E.
    Hwang, Catherine S.
    Colvard, Michelle D.
    Alliu, Veldana
    Moore, Tera
    Lin, Lewei A.
    Wyse, Jessica
    Hawkins, Eric J.
    Hagedorn, Hildi J.
    Gordon, Adam J.
    DRUG AND ALCOHOL DEPENDENCE, 2025, 271
12345